Addex Therapeutics Ltd/ CH0029850754 /
05/09/2024 16:53:19 | Chg. - | Volume | Bid15:58:25 | Ask16:43:00 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
0.077CHF | - | 23,201 Turnover: 1,781.837 |
-Bid Size: - | -Ask Size: - | 13.08 mill.CHF | - | - |
Fundamentals
FY 2023 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | -0.14 CHF | -69.57% |
EPS Diluted: | - CHF | -69.57% |
Revenues per Share: | 0.01 CHF | -23.86% |
Book Value per Share: | 0.01 CHF | -84.90% |
Cash Flow per Share: | -0.04 CHF | -68.52% |
Dividend per Share: | - CHF | - |
Total | in mill. | |
Revenues: | 1.65 CHF | 17.65% |
Net Income: | -10.56 CHF | -49.25% |
Operating Cash Flow: | -7.99 CHF | - |
Cash and Cash Equivalents: | 3.87 CHF | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | - | - |
P/S Ratio: | 7.94 | 4.98 |
P/BV ratio: | 11.42 | 7.16 |
P/CF Ratio: | -1.64 | -1.03 |
PEG: | 0.01 | - |
Earnings Yield: | -190.74% | -304.35% |
Dividend Yield: | - | - |
Market Capitalization | ||
Market Capitalization: | 13.08 mill. CHF | 8.2 mill. CHF |
Free Float Market Cap.: | - CHF | - CHF |
Market Cap. / Employee: | - CHF | - CHF |
Shares Outstanding: | 98.3 mill. |
Profitability
Gross Profit Margin: | - |
EBIT Margin: | -624.22% |
Net Profit Margin: | -640.91% |
Return on Equity: | -921.57% |
Return on Assets: | -227.41% |
Financial Strength
Liquidity I / Cash Ratio: | 133.60% |
Liquidity II / Quick Ratio: | 137.42% |
Liquidity III / Current Ratio: | 146.37% |
Debt / Equity Ratio: | 305.25% |
Dynam. Debt / Equity Ratio: | -43.75% |
Efficiency
Employees: | - |
Personal Expenses / Employee: | - CHF |
Revenues / Employee: | - CHF |
Net Income / Employee: | - CHF |
Total Assets / Employee: | - CHF |
* Fiscal Year End: | 31/12/2023 |
Accounting Standard: | IFRS |
Currency: | CHF |